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Physicians often scan a select number of journals to keep
up to date with practice evidence for patients with kidney
conditions. This raises the question of where relevant
studies are published. We performed a bibliometric analysis
using 195 renal systematic reviews. Each review used a
comprehensive method to identify all primary studies for
a focused clinical question relevant to patient care. We
compiled all the primary studies included in these reviews,
and considered where each study was published. Of the 2779
studies, 1351 (49%) were published in the top 20 journals.
Predictably, this list included Transplantation Proceedings
(5.9% of studies), Kidney International (5.3%), American
Journal of Kidney Diseases (4.7%), Nephrology Dialysis
Transplantation (4.3%), Transplantation (4.2%), and Journal of
the American Society of Nephrology (2.4%). Ten non-renal
journals were also on this list, including New England Journal
of Medicine (2.4%), Lancet (2.3%), and Diabetes Care (2.2%).
The remaining 1428 (51%) studies were published across
other 446 journals. When the disciplines of all journals were
considered, 59 were classified as renal or transplant journals
(42% of articles). Other specialties included general and
internal medicine (16%), endocrinology (diabetes) and
metabolism (6.5%), surgery (6.2%), cardiovascular diseases
(6.1%), pediatrics (4.3%), and radiology (3.3%). About half of
all renal practice evidence is published in non-renal journals.
Browsing the top journals is important. However, relevant
studies are also scattered across a large range of journals that
may not be routinely scanned by busy physicians, and
keeping up with this literature requires other continuing
education strategies.
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Physicians make better clinical decisions when they under-
stand the circumstances and preferences of their patients, and
the clinical evidence underlying the available options.1 The
public also expects that physicians are taking up new research
findings in a timely way.2 To keep up to date, clinicians
employ a number of continuing education strategies.3 A
common technique is to regularly browse a set of journals
that are perceived as relevant to clinical care.4,5 This raises the
question of where relevant studies are published. By its very
nature, nephrology draws on, and contributes to, many other
disciplines including endocrinology, cardiology, and rheu-
matology. It is possible that a substantial portion of renal
practice evidence is published in non-renal journals. To help
inform continuing physician education, we performed a
bibliometric analysis to map the degree to which various
journals publish clinical evidence relevant to renal patient
care. Our primary aim was to identify the nucleus of top
journals, and to determine the degree to which clinical
studies are scattered across journals of other disciplines. We
also characterized the features of these journals, including the
language of publication and whether they were indexed in
major bibliographic databases.
RESULTS
We compiled a total of 2779 unique primary renal studies
that were published from the years 1961 to 2005. Studies
most often addressed questions of treatment (71%), followed
by prognosis (13.7%), etiology (8%), diagnosis (6.5%), and
economics (0.3%).
The 2779 studies were published across 466 journals
(Figure 1). Of the 2779 studies, 1351 (49%) were published in
the top 20 journals ranked by publication frequency, whereas
the remaining 1428 (51%) studies were published across
another 446 journals. The scatter of studies across journals
was consistent with Bradford’s distribution. When we divided
all the studies into three zones with a roughly equal number
of studies (zone 1 – the first set consisting of the top 10
journals, zone 2 – the second set of 55 journals, and zone
3 – the third set of 401 journals), the observed ratio of journal
number among these three zones was 1:6:40 which was quite
close to the predicted distribution of 1:6:62 (i.e. 36). Stated in
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another way, of the 466 journals, 12% published 10 or more
studies, 10% five to nine studies, 5% four studies, 7% three
studies, 19% two studies, and 47% one study.
A list of the top 50 journals which published studies
relevant to the care of renal patients is presented in Table 1.
Predictably, this list included renal and transplant journals
such as Transplant Proceedings (5.9% of the studies), Kidney
International (5.3%), American Journal of Kidney Diseases
(4.7%), Nephrology Dialysis Transplantation (4.3%), Trans-
plantation (4.2%), and Journal of the American Society of
Nephrology (2.4%). For the topics within nephrology, the top
journals were dependent on the content area considered
(Table 2, Figure 2). For example, for the topic of acute kidney
injury, the journals Critical Care Medicine and Intensive Care
Medicine featured prominently. Conversely for the topic of
chronic kidney disease, the journal Diabetes Care was
important. The degree of scatter across journals was also
dependent on the content area considered (Table 2). For
example, 82% of studies published in the topic area of
transplantation were concentrated in the top 10 journals,
compared to only 32% of studies published in the topic area
of acute kidney injury. The visual map depicts journals which
published the highest number of studies relevant to each
renal topic area, as well as a cluster of journals which
published studies relevant to a variety of topic areas
(Figure 2).
When the disciplines of all 466 journals were considered,
59 journals or about 13% were classified as renal or
transplant journals which contributed 42% of the all articles.
Other specialties were common and included general and
internal medicine (16% of articles), endocrinology (diabetes)
and metabolism (6.5%), surgery (6.2%), cardiovascular disea-
ses (6.1%), pediatrics (4.3%), and radiology (3.3%) (Table 3).
Renal or transplant journals contributed 47% of all treatment
studies, 35% of all etiology studies, 28% of all articles
pertaining to prognostic questions, and 13% of all diagnostic
studies. Of all the 466 journals, 2% were not indexed in
Medline, 7% were not indexed in EMBASE, and 0.6% were
not indexed in either database. Nine percent of the journals
were published in languages other than English.
DISCUSSION
We live in the information age where the practice of medicine
is becoming increasingly complex and specialized. Medline
currently indexes over 4800 different journal titles with over
13 million citations.6 Here, we emphasized the journals
which renal practitioners can scan to keep abreast with
clinical evidence in their discipline. Physicians can anticipate
that scanning the top 20 journals will identify about half the
new practice evidence as it becomes available. Unfortunately,
the remaining studies are published across a large range of
journals, many of which are classified as non-renal. This
characteristic scattering of published evidence poses a
problem when trying to stay abreast of existing information
on a topic. It becomes increasingly less efficient for the busy
nephrologist to scan peripheral journals, where the potential
for finding relevant studies is low.
Strengths and limitations of this research
To our knowledge, this study represents the first time the
degree to which different journals publish research directly
relevant to renal patient management has been considered.
We provided different core journal sets for those nephro-
logists who review literature to support specialized practices
in transplantation, dialysis, chronic kidney disease, or
pediatric nephrology (Table 2).
We used systematic reviews to identify representative
clinical studies for this analysis. This sampling approach was
more comprehensive and objective than approaches used in
other bibliometric studies7,8 and similar to the approach
taken by Birken.9 This helped reduce the chance that possible
selection biases influenced the results. However, as with any
sampling method, there is always the potential concern that
the results do not generalize perfectly to the ‘universe’ of
available articles. Thus, the numbers provided in this report
should not be viewed as absolute. Studies published in
languages other than English may be underrepresented
because such studies are less likely to be cited by systematic
reviews.10,11 We also recognize that not all clinically relevant
studies in nephrology have been subsequently cited in a
systematic review. However, these results were very similar
when we performed the same type of analysis using primary
high-quality clinical studies identified from the Cochrane
database on renal content (data not shown). Furthermore,
systematic reviews tend to focus on areas where controversy
or uncertainty exists –which would be of interest to the target
audience of practicing nephrologists.
We did not consider the efficiency of scanning, rather in
the current analysis we ranked journals according to
publication frequency, that is, the largest number of clinically
relevant studies published within each journal. Clearly, the
oldest journals that publish the greatest number of articles
per year were favored by such an approach. All the primary
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Figure 1 | Studies relevant to the care of patients with kidney
conditions appeared in 466 different journals. Of the 2779 studies,
1351 (49%) were published in the top 20 journals ranked by
publication frequency*, whereas the remaining 1428 (51%) studies
were published across another 446 journals. *The journals which
published the highest number of studies are presented in Table 1.
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studies included in this analysis were deemed to be
sufficiently important, and of high enough quality, to be
cited by the authors of the systematic reviews. Although some
journals may publish more meritorious studies than others, it
is somewhat subjective to assess the impact of any given study
for changing a standard of care.
Utility of the study
Better characterization of the top journals in nephrology has
a number of additional benefits besides focusing the attention
of busy physicians. A number of services already exist to
increase physician awareness of new relevant research. These
include local libraries, e-mail alerts, and journals and
subscription services which summarize primary research
results.6,12–14 Such service providers can use these results to
develop systems of information retrieval, to maximize the
coverage of relevant studies across journals.
Science Citation Index Journal Impact Factors are a
measure of the frequency with which the ‘average article’ in a
journal has been cited in a particular year or period of time.
However, impact factors do not highlight which journals
publish the largest amount of clinical practice evidence.
Table 1 | Top 50 journals that published the highest number of studies relevant to renal care
Rank Journal
Percent of relevant
studies (n=2779) Cumulative percent
1 Transplantation Proceedings 5.9 5.9
2 Kidney International 5.3 11.2
3 American Journal of Kidney Diseases 4.7 15.8
4 Nephrology, Dialysis, and Transplantation 4.3 20.1
5 Transplantation 4.2 24.4
6 New England Journal of Medicine 2.4 26.8
7 Journal of the American Society of Nephrology 2.4 29.1
8 Lancet 2.3 31.5
9 Nephron 2.2 33.7
10 Diabetes Care 2.2 35.9
11 Clinical Nephrology 1.8 37.6
12 Annals of Internal Medicine 1.7 39.3
13 BMJ 1.6 40.9
14 Journal of Vascular Surgery 1.3 42.2
15 Pediatric Nephrology 1.2 43.4
16 Journal of Pediatrics 1.1 44.5
17 Journal of Urology 1.1 45.6
18 Peritoneal Dialysis International 1.1 46.7
19 Archives of Disease in Childhood 1.0 47.6
20 Radiology 1.0 48.6
21 American Journal of Medicine 0.9 49.5
22 Diabetic Medicine 0.8 50.3
23 JAMA : the journal of the American Medical Association 0.8 51.1
24 Diabetologia 0.8 51.9
25 American Journal of Nephrology 0.8 52.7
26 Diabetes Research and Clinical Practice 0.7 53.4
27 AJR. American Journal of Roentgenology 0.7 54.1
28 Archives of Internal Medicine 0.6 54.7
29 Arthritis and Rheumatism 0.6 55.4
30 Clinical transplantation 0.6 56.0
31 Journal of the American College of Cardiology 0.6 56.6
32 Critical Care Medicine 0.6 57.2
33 Intensive Care Medicine 0.6 57.8
34 QJM : monthly journal of the Association of Physicians 0.6 58.3
35 Contributions to Nephrology 0.6 58.9
36 American Journal of Cardiology 0.5 59.4
37 Diabetes 0.5 60.0
38 Transplant International 0.5 60.5
39 Circulation 0.5 61.1
40 Journal of Renal Nutrition 0.5 61.6
41 Renal Failure 0.5 62.1
42 European Journal of Vascular and Endovascular Surgery 0.5 62.6
43 Journal of Hypertension 0.5 63.1
44 Advances in Peritoneal Dialysis 0.5 63.5
45 British Journal of Surgery 0.5 64.0
46 American Journal of Hypertension 0.5 64.5
47 Journal of Diabetes and its Complications 0.4 64.9
48 European Journal of Clinical Pharmacology 0.4 65.3
49 Archives of Surgery 0.4 65.7
50 American Journal of Surgery 0.4 66.1
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The information presented here can be used by authors to
highlight which journals may be receptive to publishing
clinical research in various renal topic areas, or where to
publish their research to achieve maximal impact.
Knowledge of the journals which publish evidence
relevant to a renal practice can also improve the precision
of bibliographic search strategies to reduce extraneous
citations identified in such searches. Specifically, the strategy
can be restricted to search only those journals which publish
relevant studies.15 Improving the precision of searches would
benefit all types of users including the public, physicians,
researchers, and policy makers.
Future research
The affinity of various journals to publish studies relevant to
clinical practice is continually changing. Indeed, some
journals are discontinued while new journals are started
(e.g., American Journal of Transplantation, Clinical Journal of
the American Society of Nephrology). These results should be
replicated in the future to characterize any secular changes in
the ranked journal list.
There could be a systematic difference in the types of
studies and conclusions published in top journals, compared
to those published in more peripheral journals. If new
evidence published in peripheral journals does not change
current treatment paradigms, then reviewing such journals
may be less important.
Finally, the real daunting issue remains that we need better
methods to improve the timely translation of new health-care
knowledge into patient care. Unfortunately, increasingly
larger efforts are needed to keep current with the litera-
ture.16,17 Research into best methods for continuing medical
education remains a priority for the profession.
MATERIALS AND METHODS
Bibliometrics is the scientific study of publication patterns.18
Previous bibliometric research in nephrology has examined the
growth in published clinical trials,19 the failure of many conference
abstracts to be subsequently published as full text articles,20 and the
scientific productivity of a group of investigators.21 Although studies
of evidence dispersion across journals have been performed in other
disciplines,7,8 to our knowledge no such analysis has been performed
for renal content. To conduct this analysis, we first compiled a
representative set of renal clinical studies, and then considered the
journals where such studies were published.
A set of clinical studies derived from renal systematic reviews
The method of assembling studies is a critical first step in any
bibliometric mapping project. To avoid selection biases, we elected
Table 2 | The 20 journals which published the highest number of studies relevant to various renal topic areas
Acute kidney injury
(n=388)
Chronic kidney disease
and glomerulonephritis
(n=1062)
Chronic hemodialysis or
peritoneal dialysis
(n=585)
Kidney transplantation
(n=446)
Pediatric nephrology
(n=186)
Journal % Journal % Journal % Journal % Journal %
1 Kidney Int 4.6 Kidney Int 6.1 Am J Kidney Dis 12.0 Transplant Proc 34.0 Pediatr Nephrol 11.0
2 Am J Kidney Dis 3.9 Diabetes Care 5.5 Nephrol Dial
Transplant
8.5 Transplantation 26.0 J Pediatr 11.0
3 Crit Care Med 3.6 Nephrol Dial
Transplant
3.6 Kidney Int 7.2 Nephrol Dial
Transplant
3.8 Arch Dis Child 9.7
4 Intensive Care Med 3.6 N Engl J Med 3.4 Nephron 4.8 J Am Soc Nephrol 3.6 J Urol 9.7
5 Lancet 3.4 Am J Kidney Dis 3.0 Perit Dial Int 4.6 Transpl Int 3.4 Lancet 5.4
6 Am J Med 3.1 Ann Intern Med 2.9 Clin Nephrol 3.4 Clin Transplant 3.1 Eur J Pediatr 3.2
7 N Engl J Med 2.8 BMJ 2.8 J Am Soc Nephrol 3.2 Am J Transplant 2.2 Kidney Int 3.2
8 Nephrol Dial
Transplant
2.6 Lancet 2.4 J Vasc Surg 2.6 Kidney Int 2.2 BMJ 2.2
9 Antimicrob Agents
Chemother
2.3 Clin Nephrol 2.2 Adv Perit Dial 2.2 Lancet 2.2 J Med Assoc Thai 2.2
10 J Clin Oncol 2.1 Diabet Med 2.2 J Ren Nutr 2.1 Am J Kidney Dis 1.6 Pediatrics 2.2
11 Nephron 2.1 Diabetologia 2.1 Am J Nephrol 1.4 N Engl J Med 1.6 N Engl J Med 2.2
12 Anesth Analg 1.8 Radiology 2.0 Int J Artif Organs 1.4 Arch Surg 0.9 Acta Paediatr 1.6
13 Ann Intern Med 1.8 Diabetes Res Clin
Pract
1.9 Artif Organs 1.2 J Urol 0.9 Nippon Hinyokika
Gakkai Zasshi
1.6
14 J Am Coll Cardiol 1.8 Nephron 1.9 Scand J Urol Nephrol 1.2 Ann Intern Med 0.7 Am J Dis Child 1.1
15 QJM 1.8 J Am Soc Nephrol 1.8 N Engl J Med 1.2 J Heart Lung
Transplant
0.7 BJU Int 1.1
16 Br J Anaesth 1.5 J Vasc Surg 1.8 Blood Purif 1.0 Br J Surg 0.7 Child Nephrol Urol 1.1
17 Ren Fail 1.5 Arthritis Rheum 1.7 Dial Transplant 1.0 J Infect Dis 0.7 Clin Nephrol 1.1
18 Am J Nephrol 1.3 AJR Am J
Roentgenol
1.4 Clin Chem 0.9 Am J Nephrol 0.4 Clin Pediatr
Endocrinol
1.1
19 Anaesth Intensive
Care
1.3 Diabetes 1.4 Trans Am Soc Artif
Intern Organs
0.9 Ann Surg 0.4 Contrib Nephrol 1.1
20 Arch Intern Med 1.3 Am J Hypertens 1.2 Am J Surg 0.7 BMJ 0.4 J Am Soc Nephrol 1.1
Total for top 20
journals
48.2 Total for top 20
journals
51.2 Total for top 20
journals
61.3 Total for top 20
journals
89.9 Total for top 20
journals
72.0
The percentage of all renal studies published in each journal appears with the journal name.
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not to search bibliographic databases (i.e., Medline or EMBASE)
with kidney terms as the initial method to identify primary studies
of interest.8 Such an approach would have only emphasized articles
published in those journals indexed in each database. It is also well
recognized that even the most comprehensive search strategy often
fails to identify a number of relevant studies.22,23
Rather, we used renal systematic reviews as the source of primary
clinical studies. A well-conducted systematic review is one which
asks a focused question, uses comprehensive methods to identify all
high-quality primary studies for that question, and appraises the
methodological quality of the primary studies. Such studies often
focus on whether to use a therapy (treatment), how patients fare
(prognosis), how to best use a diagnostic test (diagnosis), or the
cause of certain conditions (etiology). Certainly, there are other
important articles in the literature which describe biology and
pathophysiology, or epidemiology other than randomized trials,
prognosis, diagnostic, and etiology studies. Some articles are
also commentaries or case reports. These latter types of articles
are not usually cited in systematic reviews. Thus, this analysis
focused on those types of study designs best suited to provide
high-quality clinical practice evidence for patients with kidney
conditions.
We identified the renal systematic reviews from a detailed search
of Medline for the years 2001–2005, the Cochrane Database of
Systematic Reviews, Cochrane Renal group records of non-Cochrane
meta-analyses, and the McMaster University Health Information
Research Unit Premium LiteratUre Service (PLUS) database (articles
published in the years 2002–2005).12 Two nephrologists used a
standardized checklist to independently confirm whether each
review was pertinent to renal care. Pairs of reviewers also
independently confirmed that each review met specified methodo-
logical criteria for quality. Methodologic criteria were met if the
following were described in the text of the review: a statement of the
clinical topic; explicit statements of the inclusion and exclusion
criteria applied for selecting primary studies for detailed review;
and methods used to identify primary studies for inclusion in the
review (i.e., which bibliographic databases or reference lists
were searched).
A total of 195 relevant unique systematic reviews, which included
meta-analyses, were identified.24–218 The reviews examined a broad
range of questions relevant to the practice of nephrology such as
whether acetylcysteine is beneficial for the prevention of acute
kidney injury, the value of fish oil for immunoglobulin A
nephropathy, proteinuria as a prognostic factor for progressive
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Figure 2 | A visual map presenting journals which published studies in five renal topic areas – acute kidney injury, kidney
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nephrology. The thickness of each line is the proportional to the number of studies published in each journal. A journal had to contribute
more than five articles to atleast one renal topic to be presented in the map.
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renal disease, and magnetic resonance angiography for the diagnosis
of renal artery stenosis. The average number of primary studies cited
per review was 17 (range 1–136). All primary studies that were
published in journals were compiled. Primary studies that were cited
in multiple systematic reviews were only counted once. Studies
published in the form of an abstract, book, or thesis were not
considered further as the purpose of this study was to characterize
journals which published renal practice evidence.
Abstracting data on studies and journals
We abstracted data both on the primary studies, and on the journals
in which they were published. For each primary study, the date of
publication, language of publication, and journal title were
abstracted. Each study was further classified by a nephrologist
according to the following five renal topics: acute kidney injury,
chronic kidney disease or glomerulonephritis, chronic hemodialysis
or peritoneal dialysis, kidney transplantation, and pediatric
nephrology. Each study was also classified according to the type of
question posed: treatment, diagnosis, prognosis, etiology, or
economics.
For each journal that published at least one primary study, we
abstracted the language of publication and whether it was indexed in
two major bibliographic databases (i.e., Medline and EMBASE).
Each journal was classified according to its primary discipline using
the US National Library of Medicine Medline journal subject terms
as a guide. Primary disciplines included nephrology and kidney
transplantation, general and internal medicine, endocrinology and
metabolism (including diabetes), cardiovascular diseases, surgery,
pediatrics, radiology, pharmacology, critical care and emergency
medicine, urology, anesthesiology, oncology, rheumatology, infec-
tious diseases, hematology, nutrition, obstetrics and gynecology, and
gastroenterology. When the title of a journal had changed, or when
two journals merged, we summed all studies under the more recent
journal name. Studies in journal supplements were also considered
to be from the originating journal. All identified journals were
ranked by publication frequency: journals that published the largest
number of relevant articles were ranked the highest, and journals
that published the lowest number of relevant articles were ranked
the lowest.
Analysis
All studies were counted and analyzed using Reference Manager
version 10.0 (ISI ResearchSoft, Philadelphia, PA, USA) and Excel
version 11.0 (Microsoft Corporation, Redmond, WA, USA) soft-
ware. Each journal which published at least one study relevant to
nephrology was ranked according to the number of renal studies
published. We hypothesized that the dispersion of renal studies
across journals would follow Bradford’s distribution. Bradford
suggested that for any given discipline, if scientific journals are
ranked in order of a decreasing number of published studies, then
the journal scatter can be characterized into a nucleus of a small
number of journals particularly devoted to the subject, and then
subsequent circumferential zones containing the same number of
studies as the nucleus, but published over an increasing larger
number of journals.18,219,220 For example, when a ranked journal list
is divided into three zones with an equal number of studies in each
zone, the number of journals in the nucleus (first zone) and two
succeeding zones (second and third zone) follows a distribution of
1:n:n2. We used aiSee 2.2.05 graph visualization software (AbsInt
Angewandte Informatik GmbH, Germany) to depict the relation-
ships between top journals for various renal topics. In the visual
map, each journal was linked to a renal topic by a line, where the
thickness of a line increased with the number of published studies.
The journal had to contribute more than 5 articles to at least one
renal topic to be represented in the visual map.
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